Agilent Acquires MassCode IP for Multiplex PCR, Plans to Commercialize Infectious Disease Panels

The company is currently collaborating with Ian Lipkin's lab at Columbia University to co-develop a set of MassTag PCR panels for infectious disease screening that it plans to commercialize some time in the next year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.